Table 3.
Vital signs and laboratory values of the study population
| Vital signs/Laboratory values | Reference Interval |
All | Surgery n = 133 |
Medicine n = 54 | p |
|---|---|---|---|---|---|
| Vital Signs ±SD | |||||
| Systolic BP | 143 ± 32 | 144 ± 32 | 140 ± 332 | 0.6 | |
| Diastolic BP | 74 ± 15 | 74 ± 14 | 74 ± 17 | 0.9 | |
| Pulse | 84 ± 18 | 82 ± 17 | 90 ± 20) | < 0.05 | |
| Respiratory Distress, N (%) | 13 (10) | 4 (5) | 9 (24) | < 0.05 | |
| Laboratory Values ±SD | |||||
| ALT (IU/L) | 0–55 | 126 ± 330 | 138 ± 369 | 99 ± 211 | 0.5 |
| AST (IU/L) | 5–34 | 166 ± 550 | 188 ± 646 | 112 ± 134 | 0.4 |
| GGT (IU/L) | 12–43 | 150 ± 217 | 122 ± 201 | 195 ± 251 | 0.1 |
| ALP (IU/L) | 38–150 | 147 ± 116 | 128 ± 87 | 192 ± 161 | < 0.05 |
| Total Bilirubin (mg/dL) | 0.2–1.3 | 1.5 ± 1.3 | 1.5 ± 1.3 | 1.7 ± 1.5 | 0.4 |
| LDH (IU/L) | 125–220 | 917 ± 2214 | 990 ± 2596 | 730 ± 427 | 0.3 |
| Creatinine (mg/dL) | 0.52–104 | 1.4 ± 3.1 | 1.4 ± 3.3 | 1.3 ± 1.2 | 0.9 |
| BUN (mg/dL) | 9–120 | 24 ± 16 | 21 ± 11 | 32 ± 23 | < 0.05 |
| BUN/CRT Ratio | 22 ± 8 | 20 ± 7 | 25 ± 10 | < 0.05 | |
| Sodium, mEq/L | 135–145 | 136 ± 4 | 136 ± 4 | 136 ± 6 | 0.9 |
| Potassium, mEq/L | 3.6–5 | 4.2 ± 0.6 | 4 ± 0.5 | 4.3 ± 0.8 | < 0.05 |
| WBC 103/uL | 3.6–10 | 14 ± 6 | 14 ± 6 | 14.0 ± 7 | 0.7 |
| Neutrophils (%) | 50–75 | 80 ± 12 | 80 ± 11 | 81 ± 12 | 0.7 |
| Platelets 103/uL | 150–450 | 229 ± 79 | 224 ± 74 | 236 ± 92 | 0.7 |
| Hemoglobin (g/dL) | 12–16 | 13 ± 2 | 14 ± 2 | 12 ± 2 | < 0.05 |
| Amylase (IU/L) | 30–125 | 208 ± 625 | 211 ± 593 | 201 ± 713 | 0.9 |
BP blood pressure, BUN blood urea nitrogen, CRT creatinine, WBC white blood cells